Abstract
88: High Dose-Rate Brachytherapy Monotherapy (Hdr-M) Versus Boost (Hdr-B) in Intermediate Risk Prostate Cancer: Propensity Score Matched Analysis of Canadian Data
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
